0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Helicobacter Pylori Infection Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-0C14981
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Helicobacter Pylori Infection Treatment Market Research Report 2023
BUY CHAPTERS

Global Helicobacter Pylori Infection Treatment Market Research Report 2025

Code: QYRE-Auto-0C14981
Report
May 2025
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Helicobacter Pylori Infection Treatment Market

The global market for Helicobacter Pylori Infection Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The Helicobacter pylori (H. pylori) treatment market refers to the market for drugs and therapies used to treat infections caused by the bacteria Helicobacter pylori. H. pylori is a common bacterium that infects the stomach lining and can lead to various gastrointestinal conditions such as gastritis, peptic ulcers, and stomach cancer.
The H. pylori treatment market is significant due to the prevalence of H. pylori infections worldwide and the potential complications associated with untreated infections. Treatment options typically involve a combination of antibiotics, proton pump inhibitors (PPIs), and other medications to eradicate the bacteria and heal the affected tissues.
The market for H. pylori treatment includes various pharmaceutical companies that develop and manufacture antibiotics and PPIs, as well as other healthcare providers involved in diagnosing and treating H. pylori infections. These companies compete to provide effective and safe treatment options and may also invest in research and development to improve therapeutic approaches.
North American market for Helicobacter Pylori Infection Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Helicobacter Pylori Infection Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Helicobacter Pylori Infection Treatment in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Helicobacter Pylori Infection Treatment include Cumberland Pharmaceuticals, Eisai Co., Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, Biohit, Phathom Pharmaceuticals, Redhill Biopharma, Takeda Pharmaceuticals, AbbVie, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Helicobacter Pylori Infection Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Helicobacter Pylori Infection Treatment.
The Helicobacter Pylori Infection Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Helicobacter Pylori Infection Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Helicobacter Pylori Infection Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Helicobacter Pylori Infection Treatment Market Report

Report Metric Details
Report Name Helicobacter Pylori Infection Treatment Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cumberland Pharmaceuticals, Eisai Co., Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, Biohit, Phathom Pharmaceuticals, Redhill Biopharma, Takeda Pharmaceuticals, AbbVie
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Helicobacter Pylori Infection Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Helicobacter Pylori Infection Treatment Market report?

Ans: The main players in the Helicobacter Pylori Infection Treatment Market are Cumberland Pharmaceuticals, Eisai Co., Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, Biohit, Phathom Pharmaceuticals, Redhill Biopharma, Takeda Pharmaceuticals, AbbVie

What are the Application segmentation covered in the Helicobacter Pylori Infection Treatment Market report?

Ans: The Applications covered in the Helicobacter Pylori Infection Treatment Market report are Hospitals, Diagnostics Laboratories, Clinics

What are the Type segmentation covered in the Helicobacter Pylori Infection Treatment Market report?

Ans: The Types covered in the Helicobacter Pylori Infection Treatment Market report are Bismuth-quadruple Therapy, Concomitant Therapy, Levofloxacin Triple Therapy, Bismuth Therapy, High-dose Dual Therapy

Recommended Reports

H. pylori Diagnostics

Peptic Ulcer Markets

Gastric Disorders & Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Helicobacter Pylori Infection Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bismuth-quadruple Therapy
1.2.3 Concomitant Therapy
1.2.4 Levofloxacin Triple Therapy
1.2.5 Bismuth Therapy
1.2.6 High-dose Dual Therapy
1.3 Market by Application
1.3.1 Global Helicobacter Pylori Infection Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Helicobacter Pylori Infection Treatment Market Perspective (2020-2031)
2.2 Global Helicobacter Pylori Infection Treatment Growth Trends by Region
2.2.1 Global Helicobacter Pylori Infection Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Helicobacter Pylori Infection Treatment Historic Market Size by Region (2020-2025)
2.2.3 Helicobacter Pylori Infection Treatment Forecasted Market Size by Region (2026-2031)
2.3 Helicobacter Pylori Infection Treatment Market Dynamics
2.3.1 Helicobacter Pylori Infection Treatment Industry Trends
2.3.2 Helicobacter Pylori Infection Treatment Market Drivers
2.3.3 Helicobacter Pylori Infection Treatment Market Challenges
2.3.4 Helicobacter Pylori Infection Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Helicobacter Pylori Infection Treatment Players by Revenue
3.1.1 Global Top Helicobacter Pylori Infection Treatment Players by Revenue (2020-2025)
3.1.2 Global Helicobacter Pylori Infection Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Helicobacter Pylori Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Helicobacter Pylori Infection Treatment Revenue
3.4 Global Helicobacter Pylori Infection Treatment Market Concentration Ratio
3.4.1 Global Helicobacter Pylori Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Helicobacter Pylori Infection Treatment Revenue in 2024
3.5 Global Key Players of Helicobacter Pylori Infection Treatment Head office and Area Served
3.6 Global Key Players of Helicobacter Pylori Infection Treatment, Product and Application
3.7 Global Key Players of Helicobacter Pylori Infection Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Helicobacter Pylori Infection Treatment Breakdown Data by Type
4.1 Global Helicobacter Pylori Infection Treatment Historic Market Size by Type (2020-2025)
4.2 Global Helicobacter Pylori Infection Treatment Forecasted Market Size by Type (2026-2031)
5 Helicobacter Pylori Infection Treatment Breakdown Data by Application
5.1 Global Helicobacter Pylori Infection Treatment Historic Market Size by Application (2020-2025)
5.2 Global Helicobacter Pylori Infection Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Helicobacter Pylori Infection Treatment Market Size (2020-2031)
6.2 North America Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Helicobacter Pylori Infection Treatment Market Size by Country (2020-2025)
6.4 North America Helicobacter Pylori Infection Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Helicobacter Pylori Infection Treatment Market Size (2020-2031)
7.2 Europe Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Helicobacter Pylori Infection Treatment Market Size by Country (2020-2025)
7.4 Europe Helicobacter Pylori Infection Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size (2020-2031)
8.2 Asia-Pacific Helicobacter Pylori Infection Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Helicobacter Pylori Infection Treatment Market Size (2020-2031)
9.2 Latin America Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Helicobacter Pylori Infection Treatment Market Size by Country (2020-2025)
9.4 Latin America Helicobacter Pylori Infection Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size (2020-2031)
10.2 Middle East & Africa Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cumberland Pharmaceuticals
11.1.1 Cumberland Pharmaceuticals Company Details
11.1.2 Cumberland Pharmaceuticals Business Overview
11.1.3 Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Introduction
11.1.4 Cumberland Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025)
11.1.5 Cumberland Pharmaceuticals Recent Development
11.2 Eisai Co.
11.2.1 Eisai Co. Company Details
11.2.2 Eisai Co. Business Overview
11.2.3 Eisai Co. Helicobacter Pylori Infection Treatment Introduction
11.2.4 Eisai Co. Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025)
11.2.5 Eisai Co. Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Introduction
11.3.4 Bio-Rad Laboratories Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Alpha Laboratories
11.5.1 Alpha Laboratories Company Details
11.5.2 Alpha Laboratories Business Overview
11.5.3 Alpha Laboratories Helicobacter Pylori Infection Treatment Introduction
11.5.4 Alpha Laboratories Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025)
11.5.5 Alpha Laboratories Recent Development
11.6 Biohit
11.6.1 Biohit Company Details
11.6.2 Biohit Business Overview
11.6.3 Biohit Helicobacter Pylori Infection Treatment Introduction
11.6.4 Biohit Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025)
11.6.5 Biohit Recent Development
11.7 Phathom Pharmaceuticals
11.7.1 Phathom Pharmaceuticals Company Details
11.7.2 Phathom Pharmaceuticals Business Overview
11.7.3 Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Introduction
11.7.4 Phathom Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025)
11.7.5 Phathom Pharmaceuticals Recent Development
11.8 Redhill Biopharma
11.8.1 Redhill Biopharma Company Details
11.8.2 Redhill Biopharma Business Overview
11.8.3 Redhill Biopharma Helicobacter Pylori Infection Treatment Introduction
11.8.4 Redhill Biopharma Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025)
11.8.5 Redhill Biopharma Recent Development
11.9 Takeda Pharmaceuticals
11.9.1 Takeda Pharmaceuticals Company Details
11.9.2 Takeda Pharmaceuticals Business Overview
11.9.3 Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Introduction
11.9.4 Takeda Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025)
11.9.5 Takeda Pharmaceuticals Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Helicobacter Pylori Infection Treatment Introduction
11.10.4 AbbVie Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025)
11.10.5 AbbVie Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Helicobacter Pylori Infection Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Bismuth-quadruple Therapy
 Table 3. Key Players of Concomitant Therapy
 Table 4. Key Players of Levofloxacin Triple Therapy
 Table 5. Key Players of Bismuth Therapy
 Table 6. Key Players of High-dose Dual Therapy
 Table 7. Global Helicobacter Pylori Infection Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Helicobacter Pylori Infection Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Helicobacter Pylori Infection Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Helicobacter Pylori Infection Treatment Market Share by Region (2020-2025)
 Table 11. Global Helicobacter Pylori Infection Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Helicobacter Pylori Infection Treatment Market Share by Region (2026-2031)
 Table 13. Helicobacter Pylori Infection Treatment Market Trends
 Table 14. Helicobacter Pylori Infection Treatment Market Drivers
 Table 15. Helicobacter Pylori Infection Treatment Market Challenges
 Table 16. Helicobacter Pylori Infection Treatment Market Restraints
 Table 17. Global Helicobacter Pylori Infection Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Helicobacter Pylori Infection Treatment Market Share by Players (2020-2025)
 Table 19. Global Top Helicobacter Pylori Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Helicobacter Pylori Infection Treatment as of 2024)
 Table 20. Ranking of Global Top Helicobacter Pylori Infection Treatment Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Helicobacter Pylori Infection Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Helicobacter Pylori Infection Treatment, Headquarters and Area Served
 Table 23. Global Key Players of Helicobacter Pylori Infection Treatment, Product and Application
 Table 24. Global Key Players of Helicobacter Pylori Infection Treatment, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Helicobacter Pylori Infection Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Type (2020-2025)
 Table 28. Global Helicobacter Pylori Infection Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Type (2026-2031)
 Table 30. Global Helicobacter Pylori Infection Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Application (2020-2025)
 Table 32. Global Helicobacter Pylori Infection Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Application (2026-2031)
 Table 34. North America Helicobacter Pylori Infection Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Helicobacter Pylori Infection Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Helicobacter Pylori Infection Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Helicobacter Pylori Infection Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Helicobacter Pylori Infection Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Helicobacter Pylori Infection Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Helicobacter Pylori Infection Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Helicobacter Pylori Infection Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Helicobacter Pylori Infection Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Cumberland Pharmaceuticals Company Details
 Table 50. Cumberland Pharmaceuticals Business Overview
 Table 51. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Product
 Table 52. Cumberland Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025) & (US$ Million)
 Table 53. Cumberland Pharmaceuticals Recent Development
 Table 54. Eisai Co. Company Details
 Table 55. Eisai Co. Business Overview
 Table 56. Eisai Co. Helicobacter Pylori Infection Treatment Product
 Table 57. Eisai Co. Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025) & (US$ Million)
 Table 58. Eisai Co. Recent Development
 Table 59. Bio-Rad Laboratories Company Details
 Table 60. Bio-Rad Laboratories Business Overview
 Table 61. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Product
 Table 62. Bio-Rad Laboratories Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025) & (US$ Million)
 Table 63. Bio-Rad Laboratories Recent Development
 Table 64. F. Hoffmann-La Roche Company Details
 Table 65. F. Hoffmann-La Roche Business Overview
 Table 66. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Product
 Table 67. F. Hoffmann-La Roche Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025) & (US$ Million)
 Table 68. F. Hoffmann-La Roche Recent Development
 Table 69. Alpha Laboratories Company Details
 Table 70. Alpha Laboratories Business Overview
 Table 71. Alpha Laboratories Helicobacter Pylori Infection Treatment Product
 Table 72. Alpha Laboratories Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025) & (US$ Million)
 Table 73. Alpha Laboratories Recent Development
 Table 74. Biohit Company Details
 Table 75. Biohit Business Overview
 Table 76. Biohit Helicobacter Pylori Infection Treatment Product
 Table 77. Biohit Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025) & (US$ Million)
 Table 78. Biohit Recent Development
 Table 79. Phathom Pharmaceuticals Company Details
 Table 80. Phathom Pharmaceuticals Business Overview
 Table 81. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Product
 Table 82. Phathom Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025) & (US$ Million)
 Table 83. Phathom Pharmaceuticals Recent Development
 Table 84. Redhill Biopharma Company Details
 Table 85. Redhill Biopharma Business Overview
 Table 86. Redhill Biopharma Helicobacter Pylori Infection Treatment Product
 Table 87. Redhill Biopharma Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025) & (US$ Million)
 Table 88. Redhill Biopharma Recent Development
 Table 89. Takeda Pharmaceuticals Company Details
 Table 90. Takeda Pharmaceuticals Business Overview
 Table 91. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Product
 Table 92. Takeda Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025) & (US$ Million)
 Table 93. Takeda Pharmaceuticals Recent Development
 Table 94. AbbVie Company Details
 Table 95. AbbVie Business Overview
 Table 96. AbbVie Helicobacter Pylori Infection Treatment Product
 Table 97. AbbVie Revenue in Helicobacter Pylori Infection Treatment Business (2020-2025) & (US$ Million)
 Table 98. AbbVie Recent Development
 Table 99. Research Programs/Design for This Report
 Table 100. Key Data Information from Secondary Sources
 Table 101. Key Data Information from Primary Sources
 Table 102. Authors List of This Report


List of Figures
 Figure 1. Helicobacter Pylori Infection Treatment Picture
 Figure 2. Global Helicobacter Pylori Infection Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Helicobacter Pylori Infection Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Bismuth-quadruple Therapy Features
 Figure 5. Concomitant Therapy Features
 Figure 6. Levofloxacin Triple Therapy Features
 Figure 7. Bismuth Therapy Features
 Figure 8. High-dose Dual Therapy Features
 Figure 9. Global Helicobacter Pylori Infection Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Helicobacter Pylori Infection Treatment Market Share by Application: 2024 VS 2031
 Figure 11. Hospitals Case Studies
 Figure 12. Diagnostics Laboratories Case Studies
 Figure 13. Clinics Case Studies
 Figure 14. Helicobacter Pylori Infection Treatment Report Years Considered
 Figure 15. Global Helicobacter Pylori Infection Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Helicobacter Pylori Infection Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Helicobacter Pylori Infection Treatment Market Share by Region: 2024 VS 2031
 Figure 18. Global Helicobacter Pylori Infection Treatment Market Share by Players in 2024
 Figure 19. Global Top Helicobacter Pylori Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Helicobacter Pylori Infection Treatment as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Helicobacter Pylori Infection Treatment Revenue in 2024
 Figure 21. North America Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Helicobacter Pylori Infection Treatment Market Share by Country (2020-2031)
 Figure 23. United States Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Helicobacter Pylori Infection Treatment Market Share by Country (2020-2031)
 Figure 27. Germany Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Helicobacter Pylori Infection Treatment Market Share by Region (2020-2031)
 Figure 35. China Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Helicobacter Pylori Infection Treatment Market Share by Country (2020-2031)
 Figure 43. Mexico Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Helicobacter Pylori Infection Treatment Market Share by Country (2020-2031)
 Figure 47. Turkey Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Helicobacter Pylori Infection Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Cumberland Pharmaceuticals Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2020-2025)
 Figure 51. Eisai Co. Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2020-2025)
 Figure 52. Bio-Rad Laboratories Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2020-2025)
 Figure 53. F. Hoffmann-La Roche Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2020-2025)
 Figure 54. Alpha Laboratories Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2020-2025)
 Figure 55. Biohit Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2020-2025)
 Figure 56. Phathom Pharmaceuticals Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2020-2025)
 Figure 57. Redhill Biopharma Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2020-2025)
 Figure 58. Takeda Pharmaceuticals Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2020-2025)
 Figure 59. AbbVie Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart